PREPARATION, CHARACTERIZATION, AND IN VIVO EVALUATION OF NANOLIPOSOMES-ENCAPSULATED BEVACIZUMAB (AVASTIN) FOR INTRAVITREAL ADMINISTRATION-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PREPARATION, CHARACTERIZATION, AND IN VIVO EVALUATION OF NANOLIPOSOMES-ENCAPSULATED BEVACIZUMAB (AVASTIN) FOR INTRAVITREAL ADMINISTRATION

Published:2009-05 Issue:5 Volume:29 Page:699-703
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

ABRISHAMI MAJID,GANAVATI SIAMAK ZAREI,SOROUSH DINA,ROUHBAKHSH MAJID,JAAFARI MAHMOUD R.,MALAEKEH-NIKOUEI BIZHAN

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference29 articles.

1. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.;Ferrara;Retina,2006

2. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.;Rich;Retina,2006

3. Intravitreal bevacizumab for treatment of choroidal neovascularization in pathologic myopia.;Tewari;Retina,2006

4. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma.;Iliev;Am J Ophthalmol,2006

5. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.;Haritoglou;Retina,2006

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Advanced are Nanocarriers for Effective Subretinal Injection?;International Journal of Nanomedicine;2024-09

2. Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks;Ageing Research Reviews;2024-07

3. Innovative Pharmaceutical Techniques for Paediatric Dosage Forms: A Systematic Review on 3D Printing, Prilling/Vibration and Microfluidic Platform;Journal of Pharmaceutical Sciences;2024-07

4. Nanoliposomes Permeability in a Microfluidic Drug Delivery Platform across a 3D Hydrogel;Pharmaceutics;2024-06-04

5. Intraocular drug delivery systems for Diabetic retinopathy: Current and future prospective;BioImpacts;2024-05-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3